Prospeo
Hero Section BackgroundHero Section Background
HitGen

HitGen Email Formats

Biotechnology ResearchFlag of CNBuilding 6, No. 8 Huigu 1st East Road, China51-100 Employees

HitGen Email Formats

HitGen uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.

FormatExamplePercentage
{first name}.{last name}@company.com
john.doe@company.com
48.2%
{first name initial}{last name}@company.com
{first name initial}doe@company.com
24.1%
{first name}@company.com
john@company.com
12.4%
{last name}.{first name}@company.com
doe.john@company.com
8.9%
{first name}{last name}@company.com
johndoe@company.com
6.4%

Key Contacts at HitGen

Flag of US

Greg Bial

Director Of Business Development

Flag of CN

Jing Huang

Assistant Director Of Strategic Planning

Flag of CN

Xuemin Cheng

Senior Director Of Computational Science

Flag of CN

Jing Chen

Executive Director, Biology

Flag of CN

Fangchao Liu

Associate Director Of Del Screening And Assay

Flag of CN

Jinsen Chen

Executive Director Of Nucleic Acid Chemistry

Flag of US

Xiaoyu Tian

Director Of Strategic Alliances

Flag of CN

Xiaoguang Bai

Director Of Medicinal Chemistry

Flag of CN

Huiyong Ma

Director

Flag of CN

Sen Gao

Director Of Del Platform,Hitgen Inc.

Company overview

HeadquartersBuilding 6, No. 8 Huigu 1st East Road, Tianfu International Bio-Town Shuangliu District, Chengdu, Sichuan 610200, CN
Phone number+862885197385
Website
NAICS541714
SIC873
Keywords
Lead Generation, Drug Discovery, Hit Identification, Protein Production And Purification, Chemical Library Synthesis, Dna Encoded Libraries, Early Phase R&D, Hit Expansion Libraries, Screening Libraries, Structure-Based Drug Design, Fragment-Based Drug Discovery, E3 Ligases, New Molecular Entities, Synthetic Therapeutic Oligonucleotide, Targeted Protein Degradation, Oligonucleotides Based Therapeutics
Founded2012
Employees51-100
Socials

About HitGen

HitGen Inc. (SSE: 688222.SH), founded in 2012, is headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. HitGen is committed to building a world-class innovative biopharmaceutical enterprise and contributing to the better life and health of mankind. Engaged in the discovery and optimization of small molecules and nucleic acid drugs, HitGen dedicates itself to cultivating an internationally leading drug discovery and optimization system centered on four key technology platforms, including DNA-encoded library technology (including DEL design, synthesis and screening, and application expansion), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), oligonucleotides based therapeutics technology (OBT), and targeted protein degradation technology (TPD). It provides new molecular entities (NMEs) at different stages of research and development for the pharmaceutical industry, through its diversified business models including research and development services, out-licensing of projects at different R&D stages, and new drug launches in the long term, with an aim to address unmet clinical needs with innovative therapeutic solutions. As a leader in the field of DEL technology, HitGen has been committed to the development, application and improvement of DEL technology since its establishment. HitGen has approximately 20 in-house drug discovery projects at different stages of research and development, among which 4 have obtained IND approvals and entered into clinical trials. HitGen is in collaboration with pharmaceutical, biotech and chemical companies, foundations and research institutes in the Americas, Asia, Europe, Africa, and Oceania. For more information, please call +86-28-85197385, +1-508-840-9646 or visit www.hitgen.com. For business development: bd@hitgen.com

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry
Director
Manager

Employees by Department

HitGen has 33 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore HitGen's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2018-06-285$39,100,000

Funding Insights

$39,100,000

Total funding amount

$39,100,000

Most recent funding amount

1

Number of funding rounds

HitGen Tech Stack

Discover the technologies and tools that power HitGen's digital infrastructure, from frameworks to analytics platforms.

Plesk

Plesk

Hosting panels

ThinkPHP

ThinkPHP

Web frameworks

Baidu Analytics

Analytics

jQuery

jQuery

JavaScript libraries

Google Tag Manager

Google Tag Manager

Tag managers

Windows Server

Windows Server

Operating systems

PHP

PHP

Programming languages

HSTS

HSTS

Security

VideoJS

VideoJS

Video players

IIS

IIS

Web servers

Swiper

Swiper

JavaScript libraries

Microsoft ASP.NET

Microsoft ASP.NET

Web frameworks

Frequently asked questions

HitGen is located in Building 6, No. 8 Huigu 1st East Road, CN.
You can reach HitGen at +862885197385.
HitGen was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.
HitGen has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.
HitGen has raised a total of $39,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles